ムーコル症治療薬のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Mucormycosis Treatment Drugs Market Insights, Forecast to 2028

• レポートコード：QY2207E10419 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界のムーコル症治療薬の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にムーコル症治療薬の世界市場のxxx％を占める「注射」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のムーコル症治療薬の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのムーコル症治療薬市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのムーコル症治療薬市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 ムーコル症治療薬のグローバル主要メーカーには、Abbott Laboratories、Biocon、Cadila Pharmaceuticals、Novartis、F. Hoffman La Roche、Merck Sharp and Dohme、Mylan Labs、Bristol Myers Squibb、Bayer、Lonza Group、Sanofi、Johnson and Johnson、Pfizer、Gilead Sciencesなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 ムーコル症治療薬市場は、種類と用途によって区分されます。世界のムーコル症治療薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 注射、経口 【用途別セグメント】 病院、診療所、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - ムーコル症治療薬製品概要 - 種類別市場（注射、経口） - 用途別市場（病院、診療所、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のムーコル症治療薬販売量予測2017-2028 - 世界のムーコル症治療薬売上予測2017-2028 - ムーコル症治療薬の地域別販売量 - ムーコル症治療薬の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ムーコル症治療薬販売量 - 主要メーカー別ムーコル症治療薬売上 - 主要メーカー別ムーコル症治療薬価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（注射、経口） - ムーコル症治療薬の種類別販売量 - ムーコル症治療薬の種類別売上 - ムーコル症治療薬の種類別価格 ・用途別市場規模（病院、診療所、その他） - ムーコル症治療薬の用途別販売量 - ムーコル症治療薬の用途別売上 - ムーコル症治療薬の用途別価格 ・北米市場 - 北米のムーコル症治療薬市場規模（種類別、用途別） - 主要国別のムーコル症治療薬市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのムーコル症治療薬市場規模（種類別、用途別） - 主要国別のムーコル症治療薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のムーコル症治療薬市場規模（種類別、用途別） - 主要国別のムーコル症治療薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のムーコル症治療薬市場規模（種類別、用途別） - 主要国別のムーコル症治療薬市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのムーコル症治療薬市場規模（種類別、用途別） - 主要国別のムーコル症治療薬市場規模（トルコ、サウジアラビア） ・企業情報 Abbott Laboratories、Biocon、Cadila Pharmaceuticals、Novartis、F. Hoffman La Roche、Merck Sharp and Dohme、Mylan Labs、Bristol Myers Squibb、Bayer、Lonza Group、Sanofi、Johnson and Johnson、Pfizer、Gilead Sciences ・産業チェーン及び販売チャネル分析 - ムーコル症治療薬の産業チェーン分析 - ムーコル症治療薬の原材料 - ムーコル症治療薬の生産プロセス - ムーコル症治療薬の販売及びマーケティング - ムーコル症治療薬の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ムーコル症治療薬の産業動向 - ムーコル症治療薬のマーケットドライバー - ムーコル症治療薬の課題 - ムーコル症治療薬の阻害要因 ・主な調査結果

Mucormycosis is a serious infection and needs to be treated with prescription antifungal medicine, usually amphotericin B, posaconazole, or isavuconazole. These medicines are given through a vein (amphotericin B, posaconazole, isavuconazole) or by mouth (posaconazole, isavuconazole).
Market Analysis and Insights: Global Mucormycosis Treatment Drugs Market
Due to the COVID-19 pandemic, the global Mucormycosis Treatment Drugs market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Injection accounting for % of the Mucormycosis Treatment Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Mucormycosis Treatment Drugs market size is valued at US$ million in 2021, while the US and Europe Mucormycosis Treatment Drugs are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Mucormycosis Treatment Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Mucormycosis Treatment Drugs include Abbott Laboratories, Biocon, Cadila Pharmaceuticals, Novartis, F. Hoffman La Roche, Merck Sharp and Dohme, Mylan Labs, Bristol Myers Squibb and Bayer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Mucormycosis Treatment Drugs Scope and Segment
Mucormycosis Treatment Drugs market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Mucormycosis Treatment Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Injection
Oral
Segment by Application
Hospitals
Clinics
Others
By Company
Abbott Laboratories
Biocon
Cadila Pharmaceuticals
Novartis
F. Hoffman La Roche
Merck Sharp and Dohme
Mylan Labs
Bristol Myers Squibb
Bayer
Lonza Group
Sanofi
Johnson and Johnson
Pfizer
Gilead Sciences
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Mucormycosis Treatment Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Mucormycosis Treatment Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Injection
1.2.3 Oral
1.3 Market by Application
1.3.1 Global Mucormycosis Treatment Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Mucormycosis Treatment Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Mucormycosis Treatment Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Mucormycosis Treatment Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Mucormycosis Treatment Drugs Sales by Region
2.4.1 Global Mucormycosis Treatment Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Mucormycosis Treatment Drugs by Region (2023-2028)
2.5 Global Mucormycosis Treatment Drugs Revenue by Region
2.5.1 Global Mucormycosis Treatment Drugs Revenue by Region (2017-2022)
2.5.2 Global Mucormycosis Treatment Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Mucormycosis Treatment Drugs Sales by Manufacturers
3.1.1 Global Top Mucormycosis Treatment Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Mucormycosis Treatment Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Mucormycosis Treatment Drugs in 2021
3.2 Global Mucormycosis Treatment Drugs Revenue by Manufacturers
3.2.1 Global Mucormycosis Treatment Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Mucormycosis Treatment Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Mucormycosis Treatment Drugs Revenue in 2021
3.3 Global Mucormycosis Treatment Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Mucormycosis Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Mucormycosis Treatment Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Mucormycosis Treatment Drugs Sales by Type
4.1.1 Global Mucormycosis Treatment Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Mucormycosis Treatment Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Mucormycosis Treatment Drugs Sales Market Share by Type (2017-2028)
4.2 Global Mucormycosis Treatment Drugs Revenue by Type
4.2.1 Global Mucormycosis Treatment Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Mucormycosis Treatment Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Mucormycosis Treatment Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Mucormycosis Treatment Drugs Price by Type
4.3.1 Global Mucormycosis Treatment Drugs Price by Type (2017-2022)
4.3.2 Global Mucormycosis Treatment Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Mucormycosis Treatment Drugs Sales by Application
5.1.1 Global Mucormycosis Treatment Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Mucormycosis Treatment Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Mucormycosis Treatment Drugs Sales Market Share by Application (2017-2028)
5.2 Global Mucormycosis Treatment Drugs Revenue by Application
5.2.1 Global Mucormycosis Treatment Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Mucormycosis Treatment Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Mucormycosis Treatment Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Mucormycosis Treatment Drugs Price by Application
5.3.1 Global Mucormycosis Treatment Drugs Price by Application (2017-2022)
5.3.2 Global Mucormycosis Treatment Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Mucormycosis Treatment Drugs Market Size by Type
6.1.1 North America Mucormycosis Treatment Drugs Sales by Type (2017-2028)
6.1.2 North America Mucormycosis Treatment Drugs Revenue by Type (2017-2028)
6.2 North America Mucormycosis Treatment Drugs Market Size by Application
6.2.1 North America Mucormycosis Treatment Drugs Sales by Application (2017-2028)
6.2.2 North America Mucormycosis Treatment Drugs Revenue by Application (2017-2028)
6.3 North America Mucormycosis Treatment Drugs Market Size by Country
6.3.1 North America Mucormycosis Treatment Drugs Sales by Country (2017-2028)
6.3.2 North America Mucormycosis Treatment Drugs Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Mucormycosis Treatment Drugs Market Size by Type
7.1.1 Europe Mucormycosis Treatment Drugs Sales by Type (2017-2028)
7.1.2 Europe Mucormycosis Treatment Drugs Revenue by Type (2017-2028)
7.2 Europe Mucormycosis Treatment Drugs Market Size by Application
7.2.1 Europe Mucormycosis Treatment Drugs Sales by Application (2017-2028)
7.2.2 Europe Mucormycosis Treatment Drugs Revenue by Application (2017-2028)
7.3 Europe Mucormycosis Treatment Drugs Market Size by Country
7.3.1 Europe Mucormycosis Treatment Drugs Sales by Country (2017-2028)
7.3.2 Europe Mucormycosis Treatment Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Mucormycosis Treatment Drugs Market Size by Type
8.1.1 Asia Pacific Mucormycosis Treatment Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Mucormycosis Treatment Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Mucormycosis Treatment Drugs Market Size by Application
8.2.1 Asia Pacific Mucormycosis Treatment Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Mucormycosis Treatment Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Mucormycosis Treatment Drugs Market Size by Region
8.3.1 Asia Pacific Mucormycosis Treatment Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Mucormycosis Treatment Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Mucormycosis Treatment Drugs Market Size by Type
9.1.1 Latin America Mucormycosis Treatment Drugs Sales by Type (2017-2028)
9.1.2 Latin America Mucormycosis Treatment Drugs Revenue by Type (2017-2028)
9.2 Latin America Mucormycosis Treatment Drugs Market Size by Application
9.2.1 Latin America Mucormycosis Treatment Drugs Sales by Application (2017-2028)
9.2.2 Latin America Mucormycosis Treatment Drugs Revenue by Application (2017-2028)
9.3 Latin America Mucormycosis Treatment Drugs Market Size by Country
9.3.1 Latin America Mucormycosis Treatment Drugs Sales by Country (2017-2028)
9.3.2 Latin America Mucormycosis Treatment Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Mucormycosis Treatment Drugs Market Size by Type
10.1.1 Middle East and Africa Mucormycosis Treatment Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Mucormycosis Treatment Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Mucormycosis Treatment Drugs Market Size by Application
10.2.1 Middle East and Africa Mucormycosis Treatment Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Mucormycosis Treatment Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Mucormycosis Treatment Drugs Market Size by Country
10.3.1 Middle East and Africa Mucormycosis Treatment Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Mucormycosis Treatment Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Corporation Information
11.1.2 Abbott Laboratories Overview
11.1.3 Abbott Laboratories Mucormycosis Treatment Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Abbott Laboratories Mucormycosis Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Abbott Laboratories Recent Developments
11.2 Biocon
11.2.1 Biocon Corporation Information
11.2.2 Biocon Overview
11.2.3 Biocon Mucormycosis Treatment Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Biocon Mucormycosis Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Biocon Recent Developments
11.3 Cadila Pharmaceuticals
11.3.1 Cadila Pharmaceuticals Corporation Information
11.3.2 Cadila Pharmaceuticals Overview
11.3.3 Cadila Pharmaceuticals Mucormycosis Treatment Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Cadila Pharmaceuticals Mucormycosis Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Cadila Pharmaceuticals Recent Developments
11.4 Novartis
11.4.1 Novartis Corporation Information
11.4.2 Novartis Overview
11.4.3 Novartis Mucormycosis Treatment Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Novartis Mucormycosis Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Novartis Recent Developments
11.5 F. Hoffman La Roche
11.5.1 F. Hoffman La Roche Corporation Information
11.5.2 F. Hoffman La Roche Overview
11.5.3 F. Hoffman La Roche Mucormycosis Treatment Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 F. Hoffman La Roche Mucormycosis Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 F. Hoffman La Roche Recent Developments
11.6 Merck Sharp and Dohme
11.6.1 Merck Sharp and Dohme Corporation Information
11.6.2 Merck Sharp and Dohme Overview
11.6.3 Merck Sharp and Dohme Mucormycosis Treatment Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Merck Sharp and Dohme Mucormycosis Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Merck Sharp and Dohme Recent Developments
11.7 Mylan Labs
11.7.1 Mylan Labs Corporation Information
11.7.2 Mylan Labs Overview
11.7.3 Mylan Labs Mucormycosis Treatment Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Mylan Labs Mucormycosis Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Mylan Labs Recent Developments
11.8 Bristol Myers Squibb
11.8.1 Bristol Myers Squibb Corporation Information
11.8.2 Bristol Myers Squibb Overview
11.8.3 Bristol Myers Squibb Mucormycosis Treatment Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Bristol Myers Squibb Mucormycosis Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bristol Myers Squibb Recent Developments
11.9 Bayer
11.9.1 Bayer Corporation Information
11.9.2 Bayer Overview
11.9.3 Bayer Mucormycosis Treatment Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Bayer Mucormycosis Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Bayer Recent Developments
11.10 Lonza Group
11.10.1 Lonza Group Corporation Information
11.10.2 Lonza Group Overview
11.10.3 Lonza Group Mucormycosis Treatment Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Lonza Group Mucormycosis Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Lonza Group Recent Developments
11.11 Sanofi
11.11.1 Sanofi Corporation Information
11.11.2 Sanofi Overview
11.11.3 Sanofi Mucormycosis Treatment Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Sanofi Mucormycosis Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Sanofi Recent Developments
11.12 Johnson and Johnson
11.12.1 Johnson and Johnson Corporation Information
11.12.2 Johnson and Johnson Overview
11.12.3 Johnson and Johnson Mucormycosis Treatment Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Johnson and Johnson Mucormycosis Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Johnson and Johnson Recent Developments
11.13 Pfizer
11.13.1 Pfizer Corporation Information
11.13.2 Pfizer Overview
11.13.3 Pfizer Mucormycosis Treatment Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Pfizer Mucormycosis Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Pfizer Recent Developments
11.14 Gilead Sciences
11.14.1 Gilead Sciences Corporation Information
11.14.2 Gilead Sciences Overview
11.14.3 Gilead Sciences Mucormycosis Treatment Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Gilead Sciences Mucormycosis Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Gilead Sciences Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Mucormycosis Treatment Drugs Industry Chain Analysis
12.2 Mucormycosis Treatment Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Mucormycosis Treatment Drugs Production Mode & Process
12.4 Mucormycosis Treatment Drugs Sales and Marketing
12.4.1 Mucormycosis Treatment Drugs Sales Channels
12.4.2 Mucormycosis Treatment Drugs Distributors
12.5 Mucormycosis Treatment Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Mucormycosis Treatment Drugs Industry Trends
13.2 Mucormycosis Treatment Drugs Market Drivers
13.3 Mucormycosis Treatment Drugs Market Challenges
13.4 Mucormycosis Treatment Drugs Market Restraints
14 Key Findings in The Global Mucormycosis Treatment Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Mucormycosis Treatment Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Injection
Table 3. Major Manufacturers of Oral
Table 4. Global Mucormycosis Treatment Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Mucormycosis Treatment Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Mucormycosis Treatment Drugs Sales by Region (2017-2022) & (K Units)
Table 7. Global Mucormycosis Treatment Drugs Sales Market Share by Region (2017-2022)
Table 8. Global Mucormycosis Treatment Drugs Sales by Region (2023-2028) & (K Units)
Table 9. Global Mucormycosis Treatment Drugs Sales Market Share by Region (2023-2028)
Table 10. Global Mucormycosis Treatment Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Mucormycosis Treatment Drugs Revenue Market Share by Region (2017-2022)
Table 12. Global Mucormycosis Treatment Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Mucormycosis Treatment Drugs Revenue Market Share by Region (2023-2028)
Table 14. Global Mucormycosis Treatment Drugs Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Mucormycosis Treatment Drugs Sales Share by Manufacturers (2017-2022)
Table 16. Global Mucormycosis Treatment Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Mucormycosis Treatment Drugs Revenue Share by Manufacturers (2017-2022)
Table 18. Mucormycosis Treatment Drugs Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Mucormycosis Treatment Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Mucormycosis Treatment Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mucormycosis Treatment Drugs as of 2021)
Table 21. Mucormycosis Treatment Drugs Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Mucormycosis Treatment Drugs Product Offered
Table 23. Date of Manufacturers Enter into Mucormycosis Treatment Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Mucormycosis Treatment Drugs Sales by Type (2017-2022) & (K Units)
Table 26. Global Mucormycosis Treatment Drugs Sales by Type (2023-2028) & (K Units)
Table 27. Global Mucormycosis Treatment Drugs Sales Share by Type (2017-2022)
Table 28. Global Mucormycosis Treatment Drugs Sales Share by Type (2023-2028)
Table 29. Global Mucormycosis Treatment Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Mucormycosis Treatment Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Mucormycosis Treatment Drugs Revenue Share by Type (2017-2022)
Table 32. Global Mucormycosis Treatment Drugs Revenue Share by Type (2023-2028)
Table 33. Mucormycosis Treatment Drugs Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Mucormycosis Treatment Drugs Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Mucormycosis Treatment Drugs Sales by Application (2017-2022) & (K Units)
Table 36. Global Mucormycosis Treatment Drugs Sales by Application (2023-2028) & (K Units)
Table 37. Global Mucormycosis Treatment Drugs Sales Share by Application (2017-2022)
Table 38. Global Mucormycosis Treatment Drugs Sales Share by Application (2023-2028)
Table 39. Global Mucormycosis Treatment Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Mucormycosis Treatment Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Mucormycosis Treatment Drugs Revenue Share by Application (2017-2022)
Table 42. Global Mucormycosis Treatment Drugs Revenue Share by Application (2023-2028)
Table 43. Mucormycosis Treatment Drugs Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Mucormycosis Treatment Drugs Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Mucormycosis Treatment Drugs Sales by Type (2017-2022) & (K Units)
Table 46. North America Mucormycosis Treatment Drugs Sales by Type (2023-2028) & (K Units)
Table 47. North America Mucormycosis Treatment Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Mucormycosis Treatment Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Mucormycosis Treatment Drugs Sales by Application (2017-2022) & (K Units)
Table 50. North America Mucormycosis Treatment Drugs Sales by Application (2023-2028) & (K Units)
Table 51. North America Mucormycosis Treatment Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Mucormycosis Treatment Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Mucormycosis Treatment Drugs Sales by Country (2017-2022) & (K Units)
Table 54. North America Mucormycosis Treatment Drugs Sales by Country (2023-2028) & (K Units)
Table 55. North America Mucormycosis Treatment Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Mucormycosis Treatment Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Mucormycosis Treatment Drugs Sales by Type (2017-2022) & (K Units)
Table 58. Europe Mucormycosis Treatment Drugs Sales by Type (2023-2028) & (K Units)
Table 59. Europe Mucormycosis Treatment Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Mucormycosis Treatment Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Mucormycosis Treatment Drugs Sales by Application (2017-2022) & (K Units)
Table 62. Europe Mucormycosis Treatment Drugs Sales by Application (2023-2028) & (K Units)
Table 63. Europe Mucormycosis Treatment Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Mucormycosis Treatment Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Mucormycosis Treatment Drugs Sales by Country (2017-2022) & (K Units)
Table 66. Europe Mucormycosis Treatment Drugs Sales by Country (2023-2028) & (K Units)
Table 67. Europe Mucormycosis Treatment Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Mucormycosis Treatment Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Mucormycosis Treatment Drugs Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Mucormycosis Treatment Drugs Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Mucormycosis Treatment Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Mucormycosis Treatment Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Mucormycosis Treatment Drugs Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Mucormycosis Treatment Drugs Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Mucormycosis Treatment Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Mucormycosis Treatment Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Mucormycosis Treatment Drugs Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Mucormycosis Treatment Drugs Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Mucormycosis Treatment Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Mucormycosis Treatment Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Mucormycosis Treatment Drugs Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Mucormycosis Treatment Drugs Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Mucormycosis Treatment Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Mucormycosis Treatment Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Mucormycosis Treatment Drugs Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Mucormycosis Treatment Drugs Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Mucormycosis Treatment Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Mucormycosis Treatment Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Mucormycosis Treatment Drugs Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Mucormycosis Treatment Drugs Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Mucormycosis Treatment Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Mucormycosis Treatment Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Mucormycosis Treatment Drugs Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Mucormycosis Treatment Drugs Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Mucormycosis Treatment Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Mucormycosis Treatment Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Mucormycosis Treatment Drugs Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Mucormycosis Treatment Drugs Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Mucormycosis Treatment Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Mucormycosis Treatment Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Mucormycosis Treatment Drugs Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Mucormycosis Treatment Drugs Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Mucormycosis Treatment Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Mucormycosis Treatment Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 105. Abbott Laboratories Corporation Information
Table 106. Abbott Laboratories Description and Major Businesses
Table 107. Abbott Laboratories Mucormycosis Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. Abbott Laboratories Mucormycosis Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Abbott Laboratories Recent Developments
Table 110. Biocon Corporation Information
Table 111. Biocon Description and Major Businesses
Table 112. Biocon Mucormycosis Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. Biocon Mucormycosis Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Biocon Recent Developments
Table 115. Cadila Pharmaceuticals Corporation Information
Table 116. Cadila Pharmaceuticals Description and Major Businesses
Table 117. Cadila Pharmaceuticals Mucormycosis Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. Cadila Pharmaceuticals Mucormycosis Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Cadila Pharmaceuticals Recent Developments
Table 120. Novartis Corporation Information
Table 121. Novartis Description and Major Businesses
Table 122. Novartis Mucormycosis Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. Novartis Mucormycosis Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Novartis Recent Developments
Table 125. F. Hoffman La Roche Corporation Information
Table 126. F. Hoffman La Roche Description and Major Businesses
Table 127. F. Hoffman La Roche Mucormycosis Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. F. Hoffman La Roche Mucormycosis Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. F. Hoffman La Roche Recent Developments
Table 130. Merck Sharp and Dohme Corporation Information
Table 131. Merck Sharp and Dohme Description and Major Businesses
Table 132. Merck Sharp and Dohme Mucormycosis Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 133. Merck Sharp and Dohme Mucormycosis Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Merck Sharp and Dohme Recent Developments
Table 135. Mylan Labs Corporation Information
Table 136. Mylan Labs Description and Major Businesses
Table 137. Mylan Labs Mucormycosis Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 138. Mylan Labs Mucormycosis Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Mylan Labs Recent Developments
Table 140. Bristol Myers Squibb Corporation Information
Table 141. Bristol Myers Squibb Description and Major Businesses
Table 142. Bristol Myers Squibb Mucormycosis Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 143. Bristol Myers Squibb Mucormycosis Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Bristol Myers Squibb Recent Developments
Table 145. Bayer Corporation Information
Table 146. Bayer Description and Major Businesses
Table 147. Bayer Mucormycosis Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 148. Bayer Mucormycosis Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Bayer Recent Developments
Table 150. Lonza Group Corporation Information
Table 151. Lonza Group Description and Major Businesses
Table 152. Lonza Group Mucormycosis Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 153. Lonza Group Mucormycosis Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Lonza Group Recent Developments
Table 155. Sanofi Corporation Information
Table 156. Sanofi Description and Major Businesses
Table 157. Sanofi Mucormycosis Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 158. Sanofi Mucormycosis Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Sanofi Recent Developments
Table 160. Johnson and Johnson Corporation Information
Table 161. Johnson and Johnson Description and Major Businesses
Table 162. Johnson and Johnson Mucormycosis Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 163. Johnson and Johnson Mucormycosis Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Johnson and Johnson Recent Developments
Table 165. Pfizer Corporation Information
Table 166. Pfizer Description and Major Businesses
Table 167. Pfizer Mucormycosis Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 168. Pfizer Mucormycosis Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Pfizer Recent Developments
Table 170. Gilead Sciences Corporation Information
Table 171. Gilead Sciences Description and Major Businesses
Table 172. Gilead Sciences Mucormycosis Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 173. Gilead Sciences Mucormycosis Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. Gilead Sciences Recent Developments
Table 175. Key Raw Materials Lists
Table 176. Raw Materials Key Suppliers Lists
Table 177. Mucormycosis Treatment Drugs Distributors List
Table 178. Mucormycosis Treatment Drugs Customers List
Table 179. Mucormycosis Treatment Drugs Market Trends
Table 180. Mucormycosis Treatment Drugs Market Drivers
Table 181. Mucormycosis Treatment Drugs Market Challenges
Table 182. Mucormycosis Treatment Drugs Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Mucormycosis Treatment Drugs Product Picture
Figure 3. Global Mucormycosis Treatment Drugs Market Share by Type in 2021 & 2028
Figure 3. Injection Product Picture
Figure 4. Oral Product Picture
Figure 5. Global Mucormycosis Treatment Drugs Market Share by Application in 2021 & 2028
Figure 6. Hospitals
Figure 7. Clinics
Figure 8. Others
Figure 9. Mucormycosis Treatment Drugs Report Years Considered
Figure 10. Global Mucormycosis Treatment Drugs Sales 2017-2028 (K Units)
Figure 11. Global Mucormycosis Treatment Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Mucormycosis Treatment Drugs Revenue 2017-2028 (US$ Million)
Figure 13. Global Mucormycosis Treatment Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Mucormycosis Treatment Drugs Sales Market Share by Region (2017-2022)
Figure 15. Global Mucormycosis Treatment Drugs Sales Market Share by Region (2023-2028)
Figure 16. North America Mucormycosis Treatment Drugs Sales YoY (2017-2028) & (K Units)
Figure 17. North America Mucormycosis Treatment Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Mucormycosis Treatment Drugs Sales YoY (2017-2028) & (K Units)
Figure 19. Europe Mucormycosis Treatment Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Mucormycosis Treatment Drugs Sales YoY (2017-2028) & (K Units)
Figure 21. Asia-Pacific Mucormycosis Treatment Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Mucormycosis Treatment Drugs Sales YoY (2017-2028) & (K Units)
Figure 23. Latin America Mucormycosis Treatment Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Mucormycosis Treatment Drugs Sales YoY (2017-2028) & (K Units)
Figure 25. Middle East & Africa Mucormycosis Treatment Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Mucormycosis Treatment Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Mucormycosis Treatment Drugs in the World: Market Share by Mucormycosis Treatment Drugs Revenue in 2021
Figure 28. Global Mucormycosis Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Mucormycosis Treatment Drugs Sales Market Share by Type (2017-2028)
Figure 30. Global Mucormycosis Treatment Drugs Revenue Market Share by Type (2017-2028)
Figure 31. Global Mucormycosis Treatment Drugs Sales Market Share by Application (2017-2028)
Figure 32. Global Mucormycosis Treatment Drugs Revenue Market Share by Application (2017-2028)
Figure 33. North America Mucormycosis Treatment Drugs Sales Market Share by Type (2017-2028)
Figure 34. North America Mucormycosis Treatment Drugs Revenue Market Share by Type (2017-2028)
Figure 35. North America Mucormycosis Treatment Drugs Sales Market Share by Application (2017-2028)
Figure 36. North America Mucormycosis Treatment Drugs Revenue Market Share by Application (2017-2028)
Figure 37. North America Mucormycosis Treatment Drugs Sales Share by Country (2017-2028)
Figure 38. North America Mucormycosis Treatment Drugs Revenue Share by Country (2017-2028)
Figure 39. United States Mucormycosis Treatment Drugs Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Mucormycosis Treatment Drugs Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Mucormycosis Treatment Drugs Sales Market Share by Type (2017-2028)
Figure 42. Europe Mucormycosis Treatment Drugs Revenue Market Share by Type (2017-2028)
Figure 43. Europe Mucormycosis Treatment Drugs Sales Market Share by Application (2017-2028)
Figure 44. Europe Mucormycosis Treatment Drugs Revenue Market Share by Application (2017-2028)
Figure 45. Europe Mucormycosis Treatment Drugs Sales Share by Country (2017-2028)
Figure 46. Europe Mucormycosis Treatment Drugs Revenue Share by Country (2017-2028)
Figure 47. Germany Mucormycosis Treatment Drugs Revenue (2017-2028) & (US$ Million)
Figure 48. France Mucormycosis Treatment Drugs Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Mucormycosis Treatment Drugs Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Mucormycosis Treatment Drugs Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Mucormycosis Treatment Drugs Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Mucormycosis Treatment Drugs Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Mucormycosis Treatment Drugs Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Mucormycosis Treatment Drugs Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Mucormycosis Treatment Drugs Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Mucormycosis Treatment Drugs Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Mucormycosis Treatment Drugs Revenue Share by Region (2017-2028)
Figure 58. China Mucormycosis Treatment Drugs Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Mucormycosis Treatment Drugs Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Mucormycosis Treatment Drugs Revenue (2017-2028) & (US$ Million)
Figure 61. India Mucormycosis Treatment Drugs Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Mucormycosis Treatment Drugs Revenue (2017-2028) & (US$ Million)
Figure 63. China Taiwan Mucormycosis Treatment Drugs Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Mucormycosis Treatment Drugs Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Mucormycosis Treatment Drugs Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Mucormycosis Treatment Drugs Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Mucormycosis Treatment Drugs Sales Market Share by Type (2017-2028)
Figure 68. Latin America Mucormycosis Treatment Drugs Revenue Market Share by Type (2017-2028)
Figure 69. Latin America Mucormycosis Treatment Drugs Sales Market Share by Application (2017-2028)
Figure 70. Latin America Mucormycosis Treatment Drugs Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Mucormycosis Treatment Drugs Sales Share by Country (2017-2028)
Figure 72. Latin America Mucormycosis Treatment Drugs Revenue Share by Country (2017-2028)
Figure 73. Mexico Mucormycosis Treatment Drugs Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Mucormycosis Treatment Drugs Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Mucormycosis Treatment Drugs Revenue (2017-2028) & (US$ Million)
Figure 76. Colombia Mucormycosis Treatment Drugs Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Mucormycosis Treatment Drugs Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Mucormycosis Treatment Drugs Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Mucormycosis Treatment Drugs Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Mucormycosis Treatment Drugs Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Mucormycosis Treatment Drugs Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Mucormycosis Treatment Drugs Revenue Share by Country (2017-2028)
Figure 83. Turkey Mucormycosis Treatment Drugs Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Mucormycosis Treatment Drugs Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Mucormycosis Treatment Drugs Revenue (2017-2028) & (US$ Million)
Figure 86. Mucormycosis Treatment Drugs Value Chain
Figure 87. Mucormycosis Treatment Drugs Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed

---